Literature DB >> 10843748

SCF, IL-1beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients.

M Tao1, B Li, J Nayini, C B Andrews, R W Huang, E Devemy, S Song, P Venugopal, H D Preisler.   

Abstract

This study compared cytokine transcript and protein levels in BM cells of normal individuals and leukemic patients. AML differed from normal in that: (1) AML marrow cells contain more IL-1beta protein than normal cells, (2) IL-1ra transcripts are absent from AML marrow cells, (3) AML marrow serum contains less IL-1ra protein than normal, (4) peripheral blood and marrow serum of AML patireents contains more SCF protein than normal serum, and (5) SCF transcripts have been detected in AML marrow biopsies and not in aspirate cells. These data suggest that unbalanced cytokine production may make a significant contribution to the abnormal behaviour of AML cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843748     DOI: 10.1006/cyto.2000.0666

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia.

Authors:  Steven M Kornblau; David McCue; Neera Singh; Wenjing Chen; Zeev Estrov; Kevin R Coombes
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

2.  Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia.

Authors:  Vindhya Vijay; Regan Miller; Gau Shoua Vue; Mida Bahareh Pezeshkian; Michael Maywood; Allison M Ast; Leylah M Drusbosky; Yuri Pompeu; Alan D Salgado; Samuel D Lipten; Timothy Geddes; Ann Marie Blenc; Yubin Ge; David A Ostrov; Christopher R Cogle; Gerard J Madlambayan
Journal:  Leuk Res       Date:  2019-07-03       Impact factor: 3.156

3.  Overcoming adaptive therapy resistance in AML by targeting immune response pathways.

Authors:  Katelyn Melgar; Morgan M Walker; LaQuita M Jones; Lyndsey C Bolanos; Kathleen Hueneman; Mark Wunderlich; Jian-Kang Jiang; Kelli M Wilson; Xiaohu Zhang; Patrick Sutter; Amy Wang; Xin Xu; Kwangmin Choi; Gregory Tawa; Donald Lorimer; Jan Abendroth; Eric O'Brien; Scott B Hoyt; Ellin Berman; Christopher A Famulare; James C Mulloy; Ross L Levine; John P Perentesis; Craig J Thomas; Daniel T Starczynowski
Journal:  Sci Transl Med       Date:  2019-09-04       Impact factor: 17.956

Review 4.  Why not treat human cancer with interleukin-1 blockade?

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

5.  Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.

Authors:  Ryan D Nipp; Arati V Rao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-06-19       Impact factor: 6.053

Review 6.  The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.

Authors:  Håkon Reikvam; Hanne Fredly; Astrid Olsnes Kittang; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2013-02-18       Impact factor: 4.546

7.  Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma.

Authors:  Eng-lai Tan; G Selvaratnam; R Kananathan; Choon-kook Sam
Journal:  BMC Cancer       Date:  2006-09-24       Impact factor: 4.430

8.  Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells.

Authors:  Maya S Nair; Ullas Mony; Deepthy Menon; Manzoor Koyakutty; Neeraj Sidharthan; Keechilat Pavithran; Shantikumar V Nair; Krishnakumar N Menon
Journal:  Int J Nanomedicine       Date:  2015-05-15

Review 9.  The cytokine network in acute myeloid leukemia.

Authors:  Michela Luciano; Peter W Krenn; Jutta Horejs-Hoeck
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

10.  Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes.

Authors:  Neemat M Kassem; Alya M Ayad; Noha M El Husseiny; Doaa M El-Demerdash; Hebatallah A Kassem; Mervat M Mattar
Journal:  J Glob Oncol       Date:  2017-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.